Organogenesis Holdings Inc (ORGO)
2.285
-0.70
(-23.32%)
USD |
NASDAQ |
Apr 25, 16:00
2.285
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Shareholders Equity (Quarterly): 278.66M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 278.66M |
September 30, 2023 | 276.86M |
June 30, 2023 | 271.28M |
March 31, 2023 | 263.70M |
December 31, 2022 | 265.67M |
September 30, 2022 | 256.33M |
June 30, 2022 | 254.38M |
March 31, 2022 | 243.23M |
December 31, 2021 | 241.34M |
September 30, 2021 | 189.17M |
June 30, 2021 | 178.92M |
March 31, 2021 | 157.29M |
December 31, 2020 | 141.81M |
September 30, 2020 | 65.47M |
June 30, 2020 | 35.75M |
March 31, 2020 | 40.30M |
Date | Value |
---|---|
December 31, 2019 | 55.58M |
September 30, 2019 | 12.81M |
June 30, 2019 | 23.20M |
March 31, 2019 | 32.56M |
December 31, 2018 | 47.04M |
September 30, 2018 | 303.17M |
June 30, 2018 | 298.24M |
March 31, 2018 | 297.88M |
December 31, 2017 | -8.555M |
September 30, 2017 | 298.51M |
June 30, 2017 | 300.63M |
March 31, 2017 | 300.25M |
December 31, 2016 | 300.11M |
September 30, 2016 | -0.0307M |
June 30, 2016 | -0.0162M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.81M
Minimum
Sep 2019
278.66M
Maximum
Dec 2023
171.15M
Average
189.17M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 460.02M |
Total Liabilities (Quarterly) | 181.36M |
Debt to Equity Ratio | 0.2377 |
Current Ratio | 2.795 |
Net Debt Paydown Yield | 0.24% |